[ET Net News Agency, 8 August 2025] UBS raised the target price for Wuxi Bio (02269) to
HKD41.2 from HKD20.3 and upgraded the rating to "buy" from "neutral".
The research house said it is positive on Wuxi Bio's preliminary H125 recovery from
H124, on track to meet full-year guidance. (rc)